Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
ACS Medicinal Chemistry Letters|February 21, 2019
<i>De Novo</i> Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 ProteaseChristoph Nitsche, Toby Passioura, Paul Varava, et al.BMC Biotechnology|June 18, 2009
Interfering ribonucleic acids that suppress expression of multiple unrelated genesToby Passioura, Mary M Gozar, Amber Goodchild, et al.BMC Immunology|July 28, 2009
Sequence determinants of innate immune activation by short interfering RNAsAmber Goodchild, Nicole Nopper, Andrew King, et al.The Biochemical Journal|January 7, 2026
De novo cyclic peptides allow visualisation of the monomeric and functional amyloid conformations of the kinase RIPK3Jessica A Buchanan, Olivia Lavidis, Nicholas Shields, et al.Journal of Medicinal Chemistry|November 14, 2025
Cell-Active Peptide Inhibitors of the FANCM-RMI InteractionLisa J Alcock, Joshua Mills, Rohan Bythell-Douglas, et al.Structure (London, England : 1993)|June 3, 2023
Discovery and characterization of cyclic peptides selective for the C-terminal bromodomains of BET family proteinsCharlotte Franck, Karishma Patel, Louise J Walport, et al.Iscience|August 7, 2024
A cyclic peptide-grafted Fc with hepatocyte growth factor functionality ameliorates hepatic fibrosis in a non-alcoholic steatohepatitis mouse modelNichole Marcela Rojas-Chaverra, Ryu Imamura, Hiroki Sato, et al.RSC Chemical Biology|February 12, 2025
Development of selective nanomolar cyclic peptide ligands as GBA1 enzyme stabilisersRebecca E Katzy, Renier H P van Neer, Maria J Ferraz, et al.Cell Chemical Biology|May 22, 2018
De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular EntryToby Passioura, Koichi Watashi, Kento Fukano, et al.Chemical Communications (Cambridge, England)|January 30, 2026
The effect of peptide size on target affinity in mRNA display-derived macrocyclic peptidesXuefei Jing, Jen Suh, Joshua Maxwell, et al.Pageof 6